FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Heron Resubmits HTX-011 Pain Drug NDA

[ Price : $8.95]

Huron Therapeutics says it has resubmitted to FDA its NDA for HTX-011, an investigational non-opioid analgesic indicated for treat...

FDA Clears Lantheus Bone Scan Index

[ Price : $8.95]

FDA clears the Lantheus automated bone scan index to be used on the GE Healthcare Xeleris platform.

Two Nexus Suits Invoke Buckman Implied Preemption

[ Price : $8.95]

Attorney James Beck says a California federal court dismissed two Nexus Pharmaceutical suits against drug compounders due to impli...

FDA Designates Agios Mitapivat Orphan Drug

[ Price : $8.95]

FDA grants an additional orphan drug designation for Agios mitapavit for treating sickle cell disease.

Indivior Paying $289 Million for Unlawful Suboxone Marketing

[ Price : $8.95]

The Justice Department says Indivior Solutions was sentenced to pay $289 million under a plea agreement for criminal charges invol...

FDA FY 21 Budget Initiatives Analyzed

[ Price : $8.95]

The Alliance for a Stronger FDA lists six programs likely to get additional funding from the FY 21 agency budget.

License for Mass Spectrometry for Covid, Other Uses

[ Price : $8.95]

Federal Register notice: FDA contemplates the grant of an exclusive patent license to Advion, Inc. (Ithaca, NY) for a government-o...

Safety Labeling Change Posted for Ocrevus

[ Price : $8.95]

FDA posts a safety labeling change for Genentechs Ocrevus.

FDA Conditions Lilly EUA with GMP Requirements

[ Price : $8.95]

FDA places GMP-related conditions on its recent emergency use authorization for Eli Lillys investigational monoclonal antibody the...

FDA Researching Return of Drug Manufacturing to U.S.

[ Price : $8.95]

FDA contracts with the University of Maryland Smith School of Business to research the possibility of increasing drug manufacturin...